Published in Br J Cancer on March 18, 2008
CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer (2008) 2.23
Nestin and other putative cancer stem cell markers in pancreatic cancer. Med Mol Morphol (2012) 2.21
CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. Cancer Res (2010) 1.78
High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. Br J Cancer (2009) 1.55
Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB. J Transl Med (2009) 1.48
CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis. PLoS One (2013) 1.25
CD133 antigen expression in ovarian cancer. BMC Cancer (2009) 1.23
Pancreatic cancer stem cells: emerging target for designing novel therapy. Cancer Lett (2012) 1.16
Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design. Int J Mol Sci (2012) 1.15
Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. BMC Cancer (2010) 1.15
Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications. Langenbecks Arch Surg (2009) 1.10
Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. BMC Cancer (2011) 1.10
Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cells. Int J Mol Sci (2015) 1.05
CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. J Gastroenterol (2010) 1.04
Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review. PLoS One (2013) 1.04
CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. BMC Cancer (2011) 1.02
New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells. Mol Cancer (2010) 1.01
Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks. Mol Cancer (2010) 1.01
Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer. Int J Clin Exp Pathol (2011) 0.99
Role of cancer stem cells in pancreatic ductal adenocarcinoma. Nat Rev Clin Oncol (2009) 0.99
Paracrine effects of stem cells in wound healing and cancer progression (Review). Int J Oncol (2014) 0.99
Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells. Onco Targets Ther (2013) 0.97
CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer. Oncotarget (2015) 0.96
Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance. Int J Clin Exp Pathol (2012) 0.94
High expression of cancer stem cell markers in cholangiolocellular carcinoma. Surg Today (2012) 0.93
Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer. Gastric Cancer (2013) 0.92
Targeted drug delivery in pancreatic cancer. Biochim Biophys Acta (2009) 0.92
Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers. J Histochem Cytochem (2011) 0.89
Significance of CD133 expression in esophageal squamous cell carcinoma. World J Surg Oncol (2013) 0.88
Comparative analysis of tumorbiology and CD133 positivity in primary and recurrent pancreatic ductal adenocarcinoma. Clin Exp Metastasis (2009) 0.87
CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis. Mol Cancer (2014) 0.87
SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells. BMC Cancer (2014) 0.86
CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis. PLoS One (2015) 0.86
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy. BMC Cancer (2014) 0.84
Single nucleotide polymorphisms of the adult intestinal stem cell marker Lgr5 in primary and metastatic colorectal cancer. Am J Transl Res (2012) 0.84
Nucleostemin expression in invasive breast cancer. BMC Cancer (2014) 0.84
CD133, Selectively Targeting the Root of Cancer. Toxins (Basel) (2016) 0.83
CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer. Oncotarget (2016) 0.83
Suppressive expression of CD274 increases tumorigenesis and cancer stem cell phenotypes in cholangiocarcinoma. Cancer Sci (2014) 0.82
Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer. Med Oncol (2012) 0.82
Molecular mechanism underlying lymphatic metastasis in pancreatic cancer. Biomed Res Int (2014) 0.82
Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition. Mol Cancer (2016) 0.82
Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties. Oncotarget (2015) 0.81
Cancer stem cells in breast cancer. Cancers (Basel) (2011) 0.80
Biomarkers and Targeted Therapy in Pancreatic Cancer. Biomark Cancer (2016) 0.79
Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients. Oncotarget (2015) 0.79
CXCR4 expression predicts early liver recurrence and poor survival after resection of pancreatic adenocarcinoma. Clin Transl Gastroenterol (2012) 0.78
Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis. Int J Clin Exp Pathol (2015) 0.78
Drug-eluting scaffold to deliver chemotherapeutic medication for management of pancreatic cancer after surgery. Int J Nanomedicine (2013) 0.78
Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma. Oncol Rep (2015) 0.77
A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells. J Neurosci Methods (2011) 0.77
The Interaction between Cancer Stem Cell Marker CD133 and Src Protein Promotes Focal Adhesion Kinase (FAK) Phosphorylation and Cell Migration. J Biol Chem (2016) 0.75
Identification of a novel subpopulation of tumor-initiating cells from gemcitabine-resistant pancreatic ductal adenocarcinoma patients. PLoS One (2013) 0.75
Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells. Stem Cells Int (2016) 0.75
CD133 antisense suppresses cancer cell growth and increases sensitivity to cisplatin in vitro. Exp Ther Med (2012) 0.75
Stem cell-directed therapies in pancreatic cancer. Curr Probl Cancer (2013) 0.75
CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. Int J Mol Sci (2016) 0.75
Abnormal tissue proliferation and life span variability in chronically irradiated dogs. Radiat Environ Biophys (2013) 0.75
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem (1981) 38.93
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2006) 24.52
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46
Identification of pancreatic cancer stem cells. Cancer Res (2007) 18.36
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell (2007) 14.87
Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res (2005) 13.89
Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A (2007) 13.58
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A (2007) 11.94
A perivascular niche for brain tumor stem cells. Cancer Cell (2007) 11.55
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res (2005) 11.52
Applying the principles of stem-cell biology to cancer. Nat Rev Cancer (2003) 8.95
AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood (1997) 7.84
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell (2007) 7.05
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res (2006) 6.77
CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res (2007) 6.21
Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology (2007) 5.75
A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood (1997) 5.04
CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci (2004) 4.76
Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A (1997) 4.04
Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer (2007) 3.80
Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res (2005) 3.74
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer (2007) 3.65
Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun (2006) 3.35
The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem (2000) 3.33
Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res (2007) 3.00
AC133/CD133/Prominin-1. Int J Biochem Cell Biol (2005) 2.80
Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res (2004) 2.54
Increased expression of stem cell markers in malignant melanoma. Mod Pathol (2006) 2.39
Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res (2007) 2.34
Expression of CD133-1 and CD133-2 in ovarian cancer. Int J Gynecol Cancer (2007) 1.72
Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int (2007) 1.67
Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer (2007) 1.66
Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol (2007) 1.62
Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst (2005) 1.60
Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name? Biochem Biophys Res Commun (2007) 1.57
Cancer statistics, 1988. CA Cancer J Clin (1988) 1.31
Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases. Clin Cancer Res (2006) 1.16
Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer (2007) 1.15
Clinical significance of midkine expression in pancreatic head carcinoma. Br J Cancer (2007) 1.12
Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis. Clin Cancer Res (2004) 1.09
Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma. BMC Cancer (2006) 0.96
Expression of AC133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells. Blood (1999) 0.95
Predictive value of Ki-67, p53 protein, and DNA content in the diagnosis of gastric carcinoma. Cancer (1999) 0.94
Stem cells in adult tissues. Semin Cell Dev Biol (2002) 0.90
Impact of lymph node micrometastasis in patients with pancreatic head cancer. World J Surg (2007) 0.85
Filamentous inclusions in nonneoplastic and neoplastic pancreas: an ultrastructural and immunogold labeling study. Ultrastruct Pathol (1996) 0.80
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell (1997) 18.91
High-copy-number and low-copy-number plasmid vectors for lacZ alpha-complementation and chloramphenicol- or kanamycin-resistance selection. Gene (1987) 9.16
A high-density rice genetic linkage map with 2275 markers using a single F2 population. Genetics (1998) 6.82
Global warming in the twenty-first century: an alternative scenario. Proc Natl Acad Sci U S A (2000) 5.02
Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature (1994) 5.00
Dynamic load at baseline can predict radiographic disease progression in medial compartment knee osteoarthritis. Ann Rheum Dis (2002) 4.89
Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology (1983) 3.67
Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene (1990) 3.66
A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 chi HTLV-I. EMBO J (1986) 3.53
Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res (2001) 3.51
Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn (1999) 3.33
Trends of measured climate forcing agents. Proc Natl Acad Sci U S A (2001) 3.30
Isolation of a DEAD-family protein gene that encodes a murine homolog of Drosophila vasa and its specific expression in germ cell lineage. Proc Natl Acad Sci U S A (1994) 3.25
Three-dimensional solution structure of the B domain of staphylococcal protein A: comparisons of the solution and crystal structures. Biochemistry (1992) 3.20
Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res (2001) 2.98
Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene (2008) 2.83
Cloning and expression of cDNA for salmon growth hormone in Escherichia coli. Proc Natl Acad Sci U S A (1985) 2.70
Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science (2000) 2.67
Comparative study on the antibacterial activity of phytochemical flavanones against methicillin-resistant Staphylococcus aureus. J Ethnopharmacol (1996) 2.57
PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet (1997) 2.44
Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest (1999) 2.44
Isolation and characterization of fra-2, an additional member of the fos gene family. Proc Natl Acad Sci U S A (1990) 2.40
Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer (1994) 2.34
In-vitro antibacterial susceptibility of bacteria taken from infected root dentine to a mixture of ciprofloxacin, metronidazole and minocycline. Int Endod J (1996) 2.33
Akt participation in the Wnt signaling pathway through Dishevelled. J Biol Chem (2001) 2.31
Dependence of the mechanical properties of actin/alpha-actinin gels on deformation rate. Nature (1987) 2.31
Climate forcings in the industrial era. Proc Natl Acad Sci U S A (1998) 2.29
The voltage-sensitive sodium channel is a bell-shaped molecule with several cavities. Nature (2001) 2.23
Color Doppler evaluation of valvular regurgitation in normal subjects. Circulation (1988) 2.21
Organic acid production by Basidiomycetes. I. Screening of acid-producing strains. Appl Microbiol (1965) 2.20
Solid phase synthesis of polynucleotides. VIII. Synthesis of mixed oligodeoxyribonucleotides by the phosphotriester solid phase method. Nucleic Acids Res (1983) 2.20
Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology (2001) 2.10
Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer (2000) 2.09
Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transplant (2010) 2.05
Two mouse piwi-related genes: miwi and mili. Mech Dev (2001) 2.05
Comparison of recombinant human PTH(1-34) (LY333334) with a C-terminally substituted analog of human PTH-related protein(1-34) (RS-66271): In vitro activity and in vivo pharmacological effects in rats. J Bone Miner Res (1999) 2.05
Three-dimensional structures of free form and two substrate complexes of an extradiol ring-cleavage type dioxygenase, the BphC enzyme from Pseudomonas sp. strain KKS102. J Mol Biol (1996) 1.98
Gene induction pathways mediated by distinct IRFs during viral infection. Biochem Biophys Res Commun (2001) 1.97
Eyelid reconstruction using a hard palate mucoperiosteal graft combined with a V-Y subcutaneously pedicled flap. Br J Plast Surg (2001) 1.96
Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest (1995) 1.95
Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst (1996) 1.93
Three-dimensional structure of a highly thermostable enzyme, 3-isopropylmalate dehydrogenase of Thermus thermophilus at 2.2 A resolution. J Mol Biol (1991) 1.92
Role of osteopontin in bone remodeling caused by mechanical stress. J Bone Miner Res (1999) 1.92
Rheological properties of living cytoplasm: a preliminary investigation of squid axoplasm (Loligo pealei). Cell Motil (1984) 1.91
Split luciferase as an optical probe for detecting protein-protein interactions in mammalian cells based on protein splicing. Anal Chem (2001) 1.91
Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity (1997) 1.89
Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells (1996) 1.86
Value of Doppler ultrasound parameters of portal vein and hepatic artery in the diagnosis of cirrhosis and portal hypertension. Am J Gastroenterol (1997) 1.85
Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst (1999) 1.85
The p40x of human T-cell leukemia virus type I is a trans-acting activator of viral gene transcription. Jpn J Cancer Res (1985) 1.83
Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo. J Exp Med (1999) 1.82
Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr (2010) 1.82
Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circ Res (1998) 1.81
The application of a homogeneous half-space model in the analysis of endothelial cell micropipette measurements. J Biomech Eng (1988) 1.81
HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme. Br J Pharmacol (2001) 1.78
Crystal structure of rat biliverdin reductase. Nat Struct Biol (2001) 1.77
alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell Immunol (2000) 1.77
Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J Biochem (1996) 1.77
Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol (2000) 1.73
Distribution and effect of iodized poppyseed oil in the liver after hepatic artery embolization: experimental study in several animal species. Radiology (1993) 1.72
An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am J Surg (1998) 1.71
Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg (1994) 1.71
Gigantic jets between a thundercloud and the ionosphere. Nature (2003) 1.70
A common-sense climate index: is climate changing noticeably? Proc Natl Acad Sci U S A (1998) 1.69
Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes. Int Immunol (1996) 1.68
Cytologic grading of invasive breast carcinoma. Correlation with clinicopathologic variables and predictive value of nodal metastasis. Acta Cytol (2000) 1.68
Portal tumor thrombus due to gastrointestinal cancer. Abdom Imaging (1999) 1.67
Rer1p, a retrieval receptor for endoplasmic reticulum membrane proteins, is dynamically localized to the Golgi apparatus by coatomer. J Cell Biol (2001) 1.67
Usefulness and limitations of ultrasonography in the initial evaluation of blunt abdominal trauma. J Trauma (1998) 1.67
MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol (2005) 1.65
Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients. Surg Neurol (2000) 1.65
Three AML patients with existing or pre-existing intracerebral granulocytic sarcomas who were successfully treated with allogeneic bone marrow transplantations. Bone Marrow Transplant (1999) 1.65
Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. J Nucl Med (1996) 1.62
Response of patients with cirrhosis who have undergone partial hepatectomy to treatment aimed at achieving supranormal oxygen delivery and consumption. Surgery (1998) 1.61
Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells (1998) 1.59
Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem (1996) 1.57
The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int Immunol (2000) 1.57
Electron-phonon coupling reflecting dynamic charge inhomogeneity in copper oxide superconductors. Nature (2006) 1.57
Renal damage and salt-dependent hypertension in aged transgenic mice overexpressing endothelin-1. J Mol Med (Berl) (2001) 1.56
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest (1994) 1.55
Genome-wide profiling of promoter methylation in human. Oncogene (2006) 1.55
A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res (1993) 1.55
Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol (2000) 1.54
Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells. J Clin Endocrinol Metab (2001) 1.54
Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells. Eur Respir J (1998) 1.53
Conversion of normal behavior to shiverer by myelin basic protein antisense cDNA in transgenic mice. Science (1988) 1.53
Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer (1994) 1.52
Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma. J Surg Oncol (2000) 1.52
Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke (1976) 1.52
Mechanical properties of actin. J Biol Chem (1985) 1.51
In vitro trans translation mediated by alanine-charged 10Sa RNA. J Mol Biol (1997) 1.50
Synthesis of deoxyoligonucleotides containing 7-deazaadenine: recognition and cleavage by restriction endonuclease Bgl II and Sau 3AI (nucleosides and nucleotides Part 55). Nucleic Acids Res (1984) 1.50
A host-dependent hybrid plasmid suitable as a suicidal carrier for transposable elements. Plasmid (1981) 1.49